InsiderClue
Insiders · Profile

Poulton Jeffrey V.

EVP, Chief Financial Officer at ALNYLAM PHARMACEUTICALS. Filing since 27 Apr 2023. CIK 0001782962

Company
Date
Role
Action
Shares
Amount
Of holding
ALNY ALNYLAM PHARMACEUTICALS, INC.
4 Mar 2026
EVP, Chief Financial Officer
Sold at will
2,468
$797.35K
3.8%
ALNY ALNYLAM PHARMACEUTICALS, INC.
2 Mar 2026
EVP, Chief Financial Officer
Sold at will
2,206
$722.80K
3.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
13 Feb 2026
EVP, Chief Financial Officer
Sold at will
2,242
$695.20K
3.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 Jan 2026
EVP, Chief Financial Officer
Sold at will
2,780
$1.01M
4.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
2 Oct 2025
EVP, Chief Financial Officer
Sold at will
3,821
$1.73M
6.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
18 Aug 2025
EVP, Chief Financial Officer
Sold at will
2,274
$1.03M
4.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
3 Mar 2025
EVP, Chief Financial Officer
Sold at will
1,264
$308.14K
2.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
28 Feb 2025
EVP, Chief Financial Officer
Sold at will
796
$192.39K
2.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
14 Feb 2025
EVP, Chief Financial Officer
Sold at will
967
$246.75K
2.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
26 Nov 2024
EVP, Chief Financial Officer
Sold at will
1,682
$422.14K
5.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
25 Jun 2024
EVP, Chief Financial Officer
Sold at will
1,605
$370.75K
5.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
28 Feb 2024
EVP, Chief Financial Officer
Sold at will
574
$89.14K
2.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
16 Feb 2024
EVP, Chief Financial Officer
Sold at will
1,007
$149.10K
5.3%
ALNY ALNYLAM PHARMACEUTICALS, INC.
4 Aug 2023
EVP, Chief Financial Officer
Sold at will
3,460
$643.04K
17.9%
ALNY ALNYLAM PHARMACEUTICALS, INC.
27 Apr 2023
EVP, Chief Financial Officer
Sold at will
977
$190.11K
7.7%
15 decisions on file.